Dual-energy X-ray absorptiometry (DXA) revealed total body fat 34.6%, visceral adipose tissue (VAT) 1,318 g, fat mass ratio (FMR) 1.146, and lower-limb adiposity 33.5% (both negative)
The drug belongs to the same class of drugGLP-1 agonistsas Ozempic, Wegovy, Zepbound and Mounjaro, and like Lillys tirzepatide, it mimics the function of two gut hormones, GLP-1 and GIP, that can control blood sugar and suppress appetite (semaglutide only mimics GLP-1)
Semaglutide: A holistic approach to weight loss and mental wellness
While the injection, Zepbound, is well-studied and shown to be effective, oral tirzepatide is limited to compounded forms without FDA approval
First- and second-line pharmacotherapies for patients with moderate to severely active ulcerative colitis: an updated network meta-analysis